There is an update to Current Procedural Terminology (CPT) regarding new codes for the bivalent COVID-19 vaccine booster doses from Moderna and Pfizer-BioNTech. The updated boosters are adapted in a single dose for the BA.4 and BA.5 Omicron subvariants and the original coronavirus strain.
The editorial update includes eight CPT codes, with four of them (91312, 91313, 0124A, and 0134A) effective for use immediately. The other Four CPT codes (91314, 91315, 0144A, and 0154A) will be effective for use after FDA ( Food and Drug Administration) authorization.
The new product and administration codes assigned to each bivalent COVID-19 vaccine booster are:
Moderna bivalent booster – 18 years and older
91313 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use
0134A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose
Moderna bivalent booster - 6 years through 11 years
91314 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use
0144A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose
Pfizer-BioNTech bivalent booster - 12 years and older
91312 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use
0124A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose
Pfizer-BioNTech bivalent booster - 5 years through 11 years
91315 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use
0154A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose
You can use the AMA's vaccine code finder to identify the appropriate CPT code combination for each patient's type and dose of the COVID-19 vaccine.
Great MRA coders perform analytical reviews of known data elements to establish a hypothesis related to
patients' future health.
Test yourself with this Challenge and earn 2 Free CEUs
(for your AAPC certification}.
Every patient must receive adequate care to live better without suffering. To reach this goal, all Healthcare Providers should be able to mobilize the resources necessary
to care for their patients.
That's why we give ourselves a tremendous and clear mission To help healthcare providers.
And encourage them to describe the true picture of their patients' Health status to improve the Risk Score Accuracy.
Comments